Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion

Published:2008-11-24 Issue:1 Volume:115 Page:94-100
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Robak Tadeusz,Blonski Jerzy Z.,Wawrzyniak Ewa,Gora-Tybor Joanna,Palacz Aleksandra,Dmoszynska Anna,Konopka Lech,Warzocha Krzysztof,Jamroziak Krzysztof

Funder

Ministry of Science, Warsaw Poland

Medical University of Lodz

Foundation for the Development of Diagnostics and Therapy, Warsaw, Poland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24003/fullpdf

Reference38 articles.

1. New prognostic markers in chronic lymphocytic leukemia;Moreno;Blood Rev.,2008

2. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;N Engl J Med.,2000

3. p53 in health and disease;Vousden;Nat Rev Mol Cell Biol.,2007

4. Characterization of TP53 abnormalities in chronic lymphocytic leukaemia;Thornton;Hematol J.,2004

5. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia;Rai;N Engl J Med.,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primer on Chronic Lymphocytic Leukemia: Part II;The Journal for Nurse Practitioners;2018-04

2. Powikłania infekcyjne i autoimmunologiczne w przewlekłej białaczce limfocytowej;Acta Haematologica Polonica;2013-07

3. In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent;Pharmacological Reports;2013-03

4. Serum Tumor Necrosis Factor-α and Interleukin-10 Levels as Markers to Predict Outcome of Patients with Chronic Lymphocytic Leukemia in Different Risk Groups Defined by the IGHV Mutation Status;Archivum Immunologiae et Therapiae Experimentalis;2012-09-04

5. Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results;Leukemia Research;2012-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3